236 related articles for article (PubMed ID: 15921820)
1. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.
Dietz BM; Mahady GB; Pauli GF; Farnsworth NR
Brain Res Mol Brain Res; 2005 Aug; 138(2):191-7. PubMed ID: 15921820
[TBL] [Abstract][Full Text] [Related]
2. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity.
Yuan CS; Mehendale S; Xiao Y; Aung HH; Xie JT; Ang-Lee MK
Anesth Analg; 2004 Feb; 98(2):353-358. PubMed ID: 14742369
[TBL] [Abstract][Full Text] [Related]
3. Valerenic acid and Valeriana officinalis extracts delay onset of Pentylenetetrazole (PTZ)-Induced seizures in adult Danio rerio (Zebrafish).
Torres-Hernández BA; Del Valle-Mojica LM; Ortíz JG
BMC Complement Altern Med; 2015 Jul; 15():228. PubMed ID: 26168917
[TBL] [Abstract][Full Text] [Related]
4. Valeriana officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation.
Nam SM; Choi JH; Yoo DY; Kim W; Jung HY; Kim JW; Kang SY; Park J; Kim DW; Kim WJ; Yoon YS; Hwang IK
Exp Gerontol; 2013 Nov; 48(11):1369-77. PubMed ID: 24055511
[TBL] [Abstract][Full Text] [Related]
5. The anxiolytic effects of a Valerian extract is based on valerenic acid.
Becker A; Felgentreff F; Schröder H; Meier B; Brattström A
BMC Complement Altern Med; 2014 Jul; 14():267. PubMed ID: 25066015
[TBL] [Abstract][Full Text] [Related]
6. Binding studies for serotoninergic, dopaminergic and noradrenergic receptors of Valeriana adscendens Trel. extracts.
Nencini C; Cavallo F; Capasso A; De Feo V; De Martino L; Bruni G; Giorgi G; Micheli L
J Ethnopharmacol; 2006 Nov; 108(2):185-7. PubMed ID: 16839726
[TBL] [Abstract][Full Text] [Related]
7. In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors.
Abourashed EA; Koetter U; Brattström A
Phytomedicine; 2004 Nov; 11(7-8):633-8. PubMed ID: 15636177
[TBL] [Abstract][Full Text] [Related]
8. Telemetry as a tool to measure sedative effects of a valerian root extract and its single constituents in mice.
Chow NK; Fretz M; Hamburger M; Butterweck V
Planta Med; 2011 May; 77(8):795-803. PubMed ID: 21154200
[TBL] [Abstract][Full Text] [Related]
9. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.
Murphy K; Kubin ZJ; Shepherd JN; Ettinger RH
Phytomedicine; 2010 Jul; 17(8-9):674-8. PubMed ID: 20042323
[TBL] [Abstract][Full Text] [Related]
10. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor.
Burdette JE; Liu J; Chen SN; Fabricant DS; Piersen CE; Barker EL; Pezzuto JM; Mesecar A; Van Breemen RB; Farnsworth NR; Bolton JL
J Agric Food Chem; 2003 Sep; 51(19):5661-70. PubMed ID: 12952416
[TBL] [Abstract][Full Text] [Related]
11. Valerian extract characterized by high valerenic acid and low acetoxy valerenic acid contents demonstrates anxiolytic activity.
Felgentreff F; Becker A; Meier B; Brattström A
Phytomedicine; 2012 Oct; 19(13):1216-22. PubMed ID: 22944521
[TBL] [Abstract][Full Text] [Related]
12. Valerenic Acid Protects Against Physical and Psychological Stress by Reducing the Turnover of Serotonin and Norepinephrine in Mouse Hippocampus-Amygdala Region.
Jung HY; Yoo DY; Nam SM; Kim JW; Choi JH; Yoo M; Lee S; Yoon YS; Hwang IK
J Med Food; 2015 Dec; 18(12):1333-9. PubMed ID: 26177123
[TBL] [Abstract][Full Text] [Related]
13. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis.
Fernández S; Wasowski C; Paladini AC; Marder M
Pharmacol Biochem Behav; 2004 Feb; 77(2):399-404. PubMed ID: 14751470
[TBL] [Abstract][Full Text] [Related]
14. Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors.
Müller CE; Schumacher B; Brattström A; Abourashed EA; Koetter U
Life Sci; 2002 Sep; 71(16):1939-49. PubMed ID: 12175708
[TBL] [Abstract][Full Text] [Related]
15. Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid.
Trauner G; Khom S; Baburin I; Benedek B; Hering S; Kopp B
Planta Med; 2008 Jan; 74(1):19-24. PubMed ID: 18095218
[TBL] [Abstract][Full Text] [Related]
16. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts.
Benke D; Barberis A; Kopp S; Altmann KH; Schubiger M; Vogt KE; Rudolph U; Möhler H
Neuropharmacology; 2009 Jan; 56(1):174-81. PubMed ID: 18602406
[TBL] [Abstract][Full Text] [Related]
17. A Review Focused on Molecular Mechanisms of Anxiolytic Effect of Valerina officinalis L. in Connection with Its Phytochemistry through in vitro/in vivo Studies.
Orhan IE
Curr Pharm Des; 2021; 27(28):3084-3090. PubMed ID: 33463459
[TBL] [Abstract][Full Text] [Related]
18. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex.
Gobbi M; Valle FD; Ciapparelli C; Diomede L; Morazzoni P; Verotta L; Caccia S; Cervo L; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):262-9. PubMed ID: 10543427
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women.
Anderson GD; Elmer GW; Taibi DM; Vitiello MV; Kantor E; Kalhorn TF; Howald WN; Barsness S; Landis CA
Phytother Res; 2010 Oct; 24(10):1442-6. PubMed ID: 20878691
[TBL] [Abstract][Full Text] [Related]
20. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
